x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Category: Market Access

    Marksman Healthcare > Blog > Market Access

25May

How to Improve Transparency with Real World Data to Support Market Access?

by MarksMan Healthcare,  0 Comments

The USFDA defines real-world data (RWD) as ‘the data relating to patient health status and/or the healthcare delivery that is routinely collected from a variety of sources’, and real-world evidence […]

Read More

18Jan

How Innovative Alternate Payment Models Are Bringing Change In Healthcare?

by MarksMan Healthcare,  0 Comments

Drug prices in the US are the highest in the world, which necessitate new or alternate payment approaches. For instance, the new treatments for hepatitis C virus (HCV) infection are […]

Read More

28May

Tapping Payers’ Data to Document the Effect of a New Therapy in the Real World

by MarksMan Healthcare,  0 Comments

Traditionally, the pharmaceutical industry has always been dependent upon the ‘push’ strategy for successful market access for products. The drug approval process, involving submission of data on efficacy, safety, and tolerability to the regulatory agencies, used to be simple; which ended with the drug being marketed to the targeted physicians and dispensed by pharmacies post approval. Thus, this whole process involved a limited set of stakeholders, viz. physicians, regulatory agencies, and pharmacies.

Read More

03Apr

Importance of Tapping Payer’s Data to Document the Effect of a New Therapy

by MarksMan Healthcare,  0 Comments

Traditionally, the pharmaceutical industry has always been dependent upon the ‘push’ strategy for successful market access for products. The drug approval process, involving submission of data on efficacy, safety, and tolerability […]

Read More

29Mar

Generating Scientific Evidence (Efficacy/Safety/Cost Data) from India

by MarksMan Healthcare,  0 Comments

Every country exercises strict control on medicines’ market access. Typically, this requires successful completion and adequate presentation of results from phase I through phase III clinical trials, bringing forward the […]

Read More

27Nov

How Are Biobetters Different From Biosimilars?

by MarksMan Healthcare,  0 Comments

The biologics market is rapidly growing, at almost twice the rate of pharma industry. Estimates are such that 7 of the top 10 global medicines by spending will be a […]

Read More

15May

Adaptive Licensing and Real World Evidence (RWE)

by MarksMan Healthcare,  0 Comments

We all want safe and effective medicines to reach patients as soon as possible, but as we know, drug development, market authorization and payer assessment are all slow sections of […]

Read More

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

Using ‘Limits’ While Developing SLR Search Strategy: Advantages and Disadvantages

April 13, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

May 15, 2023

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

May 8, 2023

Using ‘Limits’ While Developing SLR Search Strategy: Advantages and Disadvantages

April 13, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...